130 related articles for article (PubMed ID: 8993564)
21. Detection of unusual very-long-chain fatty acid and ether lipid derivatives in the fibroblasts and plasma of patients with peroxisomal diseases using liquid chromatography-mass spectrometry.
Takashima S; Toyoshi K; Itoh T; Kajiwara N; Honda A; Ohba A; Takemoto S; Yoshida S; Shimozawa N
Mol Genet Metab; 2017 Mar; 120(3):255-268. PubMed ID: 28089346
[TBL] [Abstract][Full Text] [Related]
22. Biochemistry of mammalian peroxisomes revisited.
Wanders RJ; Waterham HR
Annu Rev Biochem; 2006; 75():295-332. PubMed ID: 16756494
[TBL] [Abstract][Full Text] [Related]
23. Organelle interplay in peroxisomal disorders.
Thoms S; Grønborg S; Gärtner J
Trends Mol Med; 2009 Jul; 15(7):293-302. PubMed ID: 19560974
[TBL] [Abstract][Full Text] [Related]
24. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
[TBL] [Abstract][Full Text] [Related]
25. Brain uptake and utilization of fatty acids: applications to peroxisomal biogenesis diseases.
Watkins PA; Hamilton JA; Leaf A; Spector AA; Moore SA; Anderson RE; Moser HW; Noetzel MJ; Katz R
J Mol Neurosci; 2001; 16(2-3):87-92; discussion 151-7. PubMed ID: 11478388
[TBL] [Abstract][Full Text] [Related]
26. Clinical and Laboratory Diagnosis of Peroxisomal Disorders.
Wanders RJ; Klouwer FC; Ferdinandusse S; Waterham HR; Poll-Thé BT
Methods Mol Biol; 2017; 1595():329-342. PubMed ID: 28409475
[TBL] [Abstract][Full Text] [Related]
27. Genetic heterogeneity in patients with a disorder of peroxisomal beta-oxidation: a complementation study based on pristanic acid beta-oxidation suggesting different enzyme defects.
van Grunsven EG; Wanders RJ
J Inherit Metab Dis; 1997 Jul; 20(3):437-40. PubMed ID: 9266375
[No Abstract] [Full Text] [Related]
28. [Peroxisomal disorders; newer concept and recent studies].
Kamoshita S
Nihon Rinsho; 1990 Mar; 48(3):629-38. PubMed ID: 2192101
[No Abstract] [Full Text] [Related]
29. Peroxisomal fatty acid alpha- and beta-oxidation in health and disease: new insights.
Wanders RJ; van Roermund CW; Visser WF; Ferdinandusse S; Jansen GA; van den Brink DM; Gloerich J; Waterham HR
Adv Exp Med Biol; 2003; 544():293-302. PubMed ID: 14713243
[No Abstract] [Full Text] [Related]
30. Human disorders of peroxisome metabolism and biogenesis.
Waterham HR; Ferdinandusse S; Wanders RJ
Biochim Biophys Acta; 2016 May; 1863(5):922-33. PubMed ID: 26611709
[TBL] [Abstract][Full Text] [Related]
31. Atypical refsum disease with pipecolic acidemia and abnormal catalase distribution.
Baumgartner MR; Jansen GA; Verhoeven NM; Mooyer PA; Jakobs C; Roels F; Espeel M; Fourmaintraux A; Bellet H; Wanders RJ; Saudubray JM
Ann Neurol; 2000 Jan; 47(1):109-13. PubMed ID: 10632109
[TBL] [Abstract][Full Text] [Related]
32. Normal and defective neuronal membranes: structure and function: neuronal lesions in peroxisomal disorders.
Powers JM
J Mol Neurosci; 2001; 16(2-3):285-7; discussion 317-21. PubMed ID: 11478383
[TBL] [Abstract][Full Text] [Related]
33. Pre- and postnatal diagnosis of peroxisomal disorders using stable-isotope dilution gas chromatography--mass spectrometry.
Verhoeven NM; Kulik W; van den Heuvel CM; Jakobs C
J Inherit Metab Dis; 1995; 18 Suppl 1():45-60. PubMed ID: 9053555
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome biogenesis disorders.
Steinberg SJ; Dodt G; Raymond GV; Braverman NE; Moser AB; Moser HW
Biochim Biophys Acta; 2006 Dec; 1763(12):1733-48. PubMed ID: 17055079
[TBL] [Abstract][Full Text] [Related]
35. Lipid biomarkers for the peroxisomal and lysosomal disorders: their formation, metabolism and measurement.
Mashima R; Maekawa M
Biomark Med; 2018 Jan; 12(1):83-95. PubMed ID: 29235891
[TBL] [Abstract][Full Text] [Related]
36. Identification and diagnostic value of phytanoyl- and pristanoyl-carnitine in plasma from patients with peroxisomal disorders.
Herzog K; van Lenthe H; Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
Mol Genet Metab; 2017 Jul; 121(3):279-282. PubMed ID: 28566232
[TBL] [Abstract][Full Text] [Related]
37. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.
Paton BC; Sharp PC; Crane DI; Poulos A
J Clin Invest; 1996 Feb; 97(3):681-8. PubMed ID: 8609223
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of peroxisomal disorders with neurological involvement.
Molzer B
Padiatr Padol; 1993; 28(1):43-8. PubMed ID: 8446428
[TBL] [Abstract][Full Text] [Related]
39. [Peroxisomes--functions and disturbances in human metabolism].
Stradomska TJ
Postepy Biochem; 2011; 57(2):183-90. PubMed ID: 21913419
[TBL] [Abstract][Full Text] [Related]
40. Fatty acid composition of tissues in Refsum's disease (herodopathia atactica polyneuritiformis). Estimation of total phytanic acid accumulation.
Malmendier CL; Jonniaux G; Voet W; Van Den Bergen CJ
Biomedicine; 1974 Nov; 20(6):398-407. PubMed ID: 4141904
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
